Brazil's Bio-Manguinhos Invests More than $600 Million in Biosimilar New Final Processing Center

Industrial Info is tracking a grassroot biosimilar complex, named New Final Processing Center, that Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos is constructing in Santa Cruz, Rio de Janeiro, Brazil. The facility will include all needed production areas, from the raw material storage to fill and finish, packaging and final product storage, along with laboratories, utilities and administrative areas, to conform the Health Biotechnology Industrial Complex (CIBS).